| Literature DB >> 31125633 |
Ariane Coelho Ferraz1, Thaís de Fátima Silva Moraes2, Waleska Stephanie da Cruz Nizer1, Michelli Dos Santos3, Antônio Helvécio Tótola2, Jaqueline Maria Siqueira Ferreira3, Sidney Augusto Vieira-Filho4, Vanessa Gonçalves Rodrigues5, Lucienir Pains Duarte5, Cintia Lopes de Brito Magalhães6, José Carlos de Magalhães7.
Abstract
Mayaro virus (MAYV) is a sublethal arbovirus transmitted by mosquitoes with possible installation of an urban cycle in the Americas. Its infection causes disabling arthralgia, and still, there is no vaccine or treatment to it. We recently investigated nearly 600 compounds by molecular docking and identified epicatechin as a potent antiviral against MAYV. The root extract of Maytenus imbricata showed anti-MAYV activity and two isolated compounds from this plant were also evaluated in vitro. Proanthocyanidin (PAC), a dimer containing epicatechin, showed an effective concentration for 50% of the cells infected by MAYV (EC50) of 37.9 ± 2.4 μM and a selectivity index (SI) above 40. PAC showed significant virucidal activity, inhibiting 100% of the virus proliferation (7 log units), and caused moderate effect during adsorption and virus internalization stage. However, PAC was unable to block the infection when only the cells were pretreated. It was observed a reduction in virus yields when adding PAC at different moments after infection. The set of results indicates that PAC binds to viral and non-cellular elements and may inactivate the MAYV. The inactivation occurs before infection or when the virus reaches the extracellular environment from the 2nd cycle of infection that could block its progression cell-to-cell or to tissues not yet infected.Entities:
Keywords: Alphavirus; Antiviral effect; Celastraceae; Epicatechin; Maytenus imbricata; Metilepigalocatechin; Proanthocyanidin
Mesh:
Substances:
Year: 2019 PMID: 31125633 DOI: 10.1016/j.antiviral.2019.05.008
Source DB: PubMed Journal: Antiviral Res ISSN: 0166-3542 Impact factor: 5.970